A hybrid of selenium and an NSAID that has been shown to reduce the viability of different cancer cell lines, particularly colorectal cancer (CRC) cells (IC50 = 3.4 µM); inhibits the cell cycle in G1 and G2/M phases and induces apoptosis by activating caspase 3/7 and PARP cleavage.